Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

VISUDYNE 15 MG — DIN 02242367

VERTEPORFIN 15 MG · CHEPLAPHARM ARZNEIMITTEL GMBH · POWDER FOR SOLUTION · wholesale supply in Canada

Health Canada status: MARKETED

VISUDYNE 15 MG POWDER FOR SOLUTION - DIN 02242367
VISUDYNE — DIN 02242367. Product photograph held by Nexara Health.

What is VISUDYNE?

VISUDYNE 15 MG contains VERTEPORFIN 15 MG. It is listed in the Health Canada Drug Product Database under DIN 02242367, held by CHEPLAPHARM ARZNEIMITTEL GMBH, supplied as POWDER FOR SOLUTION for Intravenous administration. Health Canada currently lists it as marketed, status dated 22-May-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

How much does VERTEPORFIN 15 MG cost around the world?

VERTEPORFIN 15 MG is listed on 5 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Czechia publishes a max producer price (ex-factory); Greece publishes a producer price (ex-factory); Iceland publishes a max wholesale. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
Icelandmax wholesale12ISK███.██
Czechiamax producer price (ex-factory)11CZK███.██
Greeceproducer price (ex-factory)11EUR███.██
Saudi Arabiapublic11SAR███.██
South Africasingle exit price11ZAR███.██

6 pack listings across 5 brand entries and 5 price bases, refreshed 03 Sep 2026. Ranges span every VERTEPORFIN 15 MG pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label15 MG
Dosage formPOWDER FOR SOLUTION
RouteIntravenous

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02242367
DIN (unpadded, as printed on some documents)2242367
Brand nameVISUDYNE
Generic / active ingredientVERTEPORFIN 15 MG
Market authorization holderCHEPLAPHARM ARZNEIMITTEL GMBH
Health Canada schedulePRESCRIPTION
Current statusMARKETED
Status date22-May-2020
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Approved product monograph (PDF)

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for VISUDYNE

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02242367. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.